2004

Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, Leitman IM: The prevalence and predictors of herbal medicine use in surgical patients. Journal of American College of Surgeons 2004;198:583-590.

Alonzo TA, Braun TM, Moskowitz CS. Small sample estimation of relative accuracy for binary tests. Statistics in Medicine 2004;23:21-34.

Amar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Thomas B, Bach, PB, Damiano R, Thaler HT. Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. Journal of American College of Cardiology 2004;44:1248-1253.

Antonescu CR, Viale A, Sarran L, Tschernyausky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP, Besmer P: Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clinical Cancer Research 2004;10:3282-3290.

Bach PB, Elkin EB, Pastorino U, Kattan MW, Mushlin AI, Begg CB, Parkin DM: Benchmarking lung cancer mortality rates in current and former smokers. Chest 2004;126:1742-1749.

Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL: Primary care physicians who treat blacks and whites. New England Journal of Medicine 2004;351:575-584.

Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. Journal of the American Medical Association 2004;292:2765-2770.

Bacik J, Mazumdar M, Murphy BA, Fairclough DL, Eremenco S, Mariani T, Motzer RJ, Cella D: The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers. Quality of Life Research 2004;13:137-154.

Basch EM, Thaler HT, Shi W, Yakren S, Schrag D: Use of information resources by patients with cancer and their companions. Cancer 2004;100:2476-2483.

Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR: Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004;15:957-965.

Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M and Haller DG. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. Journal of Clinical Oncology 2004;22:3408-19.

Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, Thaler H, Guillem J, Paty P, Cohen AM, Wong WD. Neuroendocrine Carcinomas of the Colon and Rectum. Neuroendocrine carcinomas of the colon and rectum. Diseases of the Colon and Rectum 2004;47:163-9.

Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr., Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Borresen-Dale AL, Concannon P. Thompson WD, Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Research and Treatment 2004;6:R199-214.

Berwick M, Matullo G, Song YS, Guarrera S, Dominguez G, Orlow I, Walker M, Vineis P: Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma. Journal of Clinical Oncology 2004;22:3997-4001.

Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CB: Estimating the relative risk of developing melanoma in INK4A carriers. European Journal of Cancer Prevention 2004;13:65-70.

Brenner B, Ilson DH, Minsky BD, Bains MS, Tong W, Gonen M, Kelsen DP: Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. Journal of Clinical Oncology 2004;22:45-52.

Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP: Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. British Journal of Cancer 2004;90:1720-1726.

Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA: Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism 2004;89:4422-4427.

Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG, Brady MS: Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. American Journal of Surgical Pathology 2004;28:1518-1525.

Cai T Moskowitz CS: Semi-parametric estimation of the binormal ROC curve for a continuous diagnostic test. Biostatistics 2004;5:573-586.

Carlo WF, Hummer AJ, Schwartz L, Sullivan D, Gonen M, Jarnagin W, Fong Y, Kemeny N: Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. Journal of Surgical Oncology 2004;87:85-90.

Cassileth BR, Vickers AJ. Massage therapy for symptom control: Outcome study at a major cancer center. Journal of Pain and Symptom Management 2004;28:244-9.

Cassileth BR, Vickers AJ. Complementary therapy. In: Prostate Cancer. Ed by P Carroll and A D'Amico. New York: Lippincott, Williams and Wilkins 2004

Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM: Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025-2030.

Chang DZ, Panageas KS, Osman I, Polsky D, Busam K, Chapman PB: Clinical significance of BRAF mutations in metastatic melanoma. Journal of Translational Medicine 2004;2:46.

Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the condensed Memorial symptom assessment scale (CMSAS). Cancer Investigation 2004;22:526-53.

Chang VT, Hwang SS, Thaler HT, Kasimis B, Portenoy RK. The Memorial symptom assessment scale. Expert Review of Pharmacoeconomics and Outcomes Research 2004;4:171-178.

Chi DS, Abu-Rustum NR, Sonoda Y, Awtrey C, Hummer A, Venkatraman ES, Franklin CC, Hamilton F, Gemignani ML, Barakat RR: Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy. American Journal of Obstetrics and Gynecology 2004;191:1138-1145.

Chi SN, Conklin LS, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R: The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience. Pediatric Blood Cancer 2004;42:46-51.

Christos PJ, Oliveria SA, Masse LC, McCormick LK, Halpern AC: Skin cancer prevention and detection by nurses: attitudes, perceptions, and barriers. Journal of Cancer Education 2004;19:50-57.

Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE: Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548-555.

Couedel C, Mills KD, Barchi M, Shen L, Olshen A, Johnson RD, Nussenzweig A, Essers J, Kanaar R, Li GC, Alt FW, Jasin M: Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells. Genes and Development 2004;18:1293-1304.

Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT: Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. Journal of Vascular and Interventional Radiology 2004;15:479-483.

D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Annals of Surgery 2004;240:808-816.

Dang CT, D'Andrea GM, Moynahan ME, Dickler MN, Seidman AD, Fornier M, Robson ME, Theodoulou M, Lake D, Currie VE, Hurria A, Panageas KS, Norton L, Hudis CA: Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer. Clinical Cancer Research 2004;10:5754-5761.

Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D'Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA: Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clinical Cancer Research 2004;10:4062-4067.

Darvishian F, Hummer AJ, Thaler HT, Bhargava R, Linkov I, Asher M, Soslow RA: Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. American Journal of Surgical Pathology 2004;28:1568-1578.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V: Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. Journal of Clinical Oncology 2004;22:3255-3260.

Duffield-Lillico AJ, Begg CB: Reflections on the landmark studies of beta-carotene supplementation. Journal of the National Cancer Institute 2004;96:1729-1731.

Duffield-Lillico AJ, Shureiqi I, Lippman SM. Can selenium prevent colorectal cancer? A signpost from epidemiology. Journal of the National Cancer Institute 2004;96:1645-1647.

Dupont J, Wang X, Marchall DS, Leitao M, Hedvat CV, Hummer A, Thaler H, O'Reilly RJ, Soslow R. Wilms tumor gene (WT1) and p53 expression in ovarian and endometrial carcinomas: a study of 217 cases using tissue microarrays. Gynecologic Oncology 2004;94:449-455.

Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, Sabbatini P, Anderson S, Aghajanian C, Holland EC, Spriggs DR: Early detection and prognosis of ovarian cancer using serum YKL-40. Journal of Clinical Oncology 2004;22:3330-3339.

Eilber FC, Eilber FR, Eckardt J, Rosen G, Riedel E, Maki RG, Brennan MF, Singer S: The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Annals of Surgery 2004;240:686-695; discussion 695-697.

Elkin EB, Cowen ME, Cahill D, Steffel M, Kattan MW: Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example. Medical Decision Making 2004;24:504-510.

Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC: HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. Journal of Clinical Oncology 2004;22:854-863.

Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J: Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecologic Oncology 2004;92:719-725.

Fretts RC, Elkin EB, Myers ER, Heffner LJ: Should older women have antepartum testing to prevent unexplained stillbirth? Obstetrics and Gynecology 2004;104:56-64.

Funt SA, Hricak H, Abu-Rustum N, Mazumdar M, Felderman H, Chi DS: Role of CT in the management of recurrent ovarian cancer. American Journal of Roentgenology 2004;182:393-398.

Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC: Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. Journal of the American Board of Family Practice 2004;17:416-423.

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K: Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Research 2004;64:8891-8900.

Gonen M: Sample size and power for McNemar's test with clustered data. Statistical Methods in Medical Research 2004;23:2283-2294.

Grobmyer SR, Maki RG, Demetri GD, Mazumdar M, Riedel E, Brennan MF, Singer S: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Annals of Oncology 2004;15:1667-1672.

Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S: Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. Journal of American College of Surgeons 2004;199:1-7.

Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y: Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Annals of Surgical Oncology 2004;11:310-315.

Heller G: Incorporating follow-up time in M-estimation for survival data. Lifetime Data Analysis 2004;10:51-64.

Heller G, Venkatraman ES. A nonparametric test to compare survival distributions with covariate adjustment. Journal of the Royal Statistical Society, Series B 2004; 66 719-733.

Hershman D, Jacobson S, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecologic Oncology 2004;94: 540-549.

Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. American Journal of Pathology 2004;164:217-227.

Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. International Journal of Radiation Oncology Biology Physics 2004;59:752-759.

Houldsworth J, Olshen AB, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J, Palanisamy N, Shen Y, Dyomina K, Petlakh M, Pan Q, Zelenetz AD, Dalla-Favera R, Chaganti RS: Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood. 2004;103:1862-1868.

Hricak H, Wang L, Wei DC, Coakley FV, Akin O, Reuter VE, Gonen M, Kattan MW, Onyebuchi CN, Scardino PT: The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004;100: 2655-2663.

Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR: Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Human Pathology 2004;35:612-621.

Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr., Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM, National Heart, Lung and Blood Institute's Asthma Clinical Research Network: Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial Lancet 2004;364:1505-1512.

Janetzki S, Schaed S, Blachere NE, Ben-Porat L, Houghton AN, Panageas KS: Evaluation of elispot assays: influence of method and operator on variability of results. Journal of Immunological Methods 2004;291:175-183.

Kalish RB, McCullough L, Gupta M, Thaler HT, Chervenak FA. Intrapartum elective cesarean delivery: A previously unrecognized clinical entity. Obstetrics and Gynecology 2004;103:1137-1141

Kalish RB, Thaler HT, Chasen ST, Gupta M, Berman SJ, Rosenwaks Z, Chevenak FA: First- and second-trimester ultrasound assessment of gestational age. American Journal of Obstetrics and Gynecology 2004;191:975-978.

Kattan MW, Giri D, Panageas KS, Hummer A, Cranor M, Van Zee KJ, Hudis CA, Norton L, Borgen PI, Tan LK: A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer 2004;101:2509-2515.

Kattan MW, Vickers AJ. Incorporating predictions of individual patient risk in clinical trials. Urologic Oncology 2004;22(4):348-52.

Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O'Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH: Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 2004;103:3684-3688.

King TA, Gemignani ML, Li W, Giri DD, Panageas KS, Bogomolniy F, Arroyo C, Olvera N, Robson ME, Offit K, Borgen PI, Boyd J: Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. Cancer Research 2004;64:5051-5053.

Kirchhoff T, Satagopan JM, Kauff ND, Huang H, Kolachana P, Palmer C, Rapaport H, Nafa K, Ellis NA, Offit K: Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. Journal of the National Cancer Institute 2004;96:68-70.

Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, Gulati T, Wadsworth E, Donat S, Robson ME, Ellis N, Offit K. "BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews". Clinical Cancer Research 2004;10:2918-2921.

Kondagunta GV, Bacik J, Schwartz L, Sheinfeld J, Bajorin D, Vuky J, Marion S, Mazumdar M, Bosl GJ, Motzer RJ: Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. Investigational New Drugs. 2004;22:177-179.

Kondagunta GV, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, Mazumdar M, Motzer RJ: Phase II trial of bortezomib for patients with advanced renal cell carcinoma. Journal of Clinical Oncology 2004;22:3720-3725.

Kondagunta GV, Sheinfeld J, Mazumdar M, Marianai TV, Bajorin D, Bacik J, Bosl GJ, Motzer RJ: Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. Journal of Clinical Oncology 2004;22:464-467.

Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV: Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Molecular Cancer 2004;3:16.

La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, Rosen N, Wolden S, Cheung NK. The impact of gross total resection on local control and survival in high-risk neuroblastoma. Journal of Pediatric Surgery 2004;39:412-417.

Leitao MM Jr, Boyd J, Hummer A, Olvera N, Arroyo CD, Venkatraman E, Baergen RN, Dizon DS, Barakat RR, Soslow RA. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. American Journal of Surgical Pathology 2004;28:147-59.

Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S:Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004;101:1455-1462.

Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ, Habbema JD: National Polyp Study data: evidence for regression of adenomas. International Journal of Cancer 2004;111:633-639.

Marghoob AA, Dusza S, Oliveria S, Halpern AC: Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Archives of Dermatology 2004;140:171-175.

Marshall JR, Reid ME, Duffield-Lillico AJ. RESPONSE: Re: Selenium supplementation and the secondary prevention of non-melanoma skin cancer in a randomized trial. Journal of the National Cancer Institute 2004;96:333-334.

Mazumdar M, Smith A, Schwartz LH: A statistical simulation study finds discordance between WHO criteria and RECIST guideline. Journal of Clinical Epidemiology 2004;57:358-365.

Mazumdar M: Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners. Medical Decision Making 2004;24:525-533.

Meyerhardt JA, Tepper JE, NiedzwieckiD , Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RK, Willett CG, MacDonald JS, Benson AB, and Fuchs CS. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. Journal of Clinical Oncology 2004;22:166-74.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT: Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. Journal of Clinical Oncology 2004;22:1103-1109.

Mitra N, Ye TZ, Smith A, Chuai S, Kirchhoff T, Peterlongo P, Nafa K, Phillips MS, Offit K, Ellis NA: Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping. Cancer Research 2004;64:8116-8125.

Monge P, Wesseling C, Engel LS, Keifer M, Zuurbier M, Rojas M, Partanen T: An icon-based interview for the assessment of occupational pesticide exposure in a case-control study of childhood leukemia. International Journal of Occupational Environmental Health 2004;10:72-78.

Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. Journal of Clinical Oncology 2004;22:3113-3119.193.

Moore HG, Shia J, Klimstra DS, Ruo L, Mazumdar M, Schwartz GK, Minsky BD, Saltz L, Guillem JG: Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Annals of Surgical Oncology 2004;11:955-961.

Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG: Colorectal cancer pelvic recurrences: determinants of resectability. Diseases of the Colon and Rectum 2004;47:1599-1606.

Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HJ 3^rd: Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 2004;100:929-934.

Mora J, Alaminos M, de Torres C, Illei P, Qin J, Cheung NK, Gerald WL: Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. British Journal of Cancer 2004;91:1112-1118.

Moskowitz CS, Pepe MS: Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Statistics in Medicine 2004;23:1555-1570.

Moskowitz CS, Pepe MS. Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes. Biostatistics 2004;5:113-127.

Motzer RJ, Bacik J, Mazumdar M: Prognostic factors for survival of patients with stageIV renal cell carcinoma memorial sloan-kettering cancer center experience. Clinical Cancer Research 2004;10:6302S-6303S.

Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M: Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Journal of Clinical Oncology 2004; 22: 454-463.

Motzer RJ, Mazumdar M: Predicting survival of patients with metastatic renal cell carcinoma. Urologe Ausgabe 2004;43 Suppl 3:135-136.

O'Brien MJ, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, Gottlieb LS, Bond JH, Waye JD, Schapiro M, National Polyp Study Workgroup: Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clinical Gastroenterology Hepatology 2004;2:905-911.

Olgac S, Mazumdar M, Dalbagni G, Reuter VE: Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. American Journal of Surgical Pathology 2004;28:1545-1552.

Oliveria SA, Chau D, Christos PJ, Charles CA, Mushlin AI, Halpern AC: Diagnostic accuracy of patients in performing skin self-examination and the impact of photography. Archives of Dermatology 2004;140:57-62.

Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC: Patient adherence to skin self-examination. effect of nurse intervention with photographs. American Journal of Preventative Medicine 2004; 26:152-155.

Oliveria SA, Geller AC, Dusza SW, Marghoob AA, Sachs D, Weinstock MA, Buckminster M, Halpern AC: The Framingham school nevus study: a pilot study. Archives of Dermatology 2004;140:545-551.

Olshen AB, Venkatraman ES, Lucito R, Wigler M: Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-572.

Olson SH, Carlson MD, Ostrer H, Harlap S, Stone A, Winters M, Ambrosone CB: Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecologic Oncology 2004;93:615-620.

Osman I, Kang M, Lee A, Polsky D, Chang C, David D, Mitra N, Wu X, Sun T, Bajorin D: Clinical implications of detection of circulating bladder cancer cells expressing uroplakins and epidermal growth factor receptor. International Journal of Cancer 2004;111:934-939.

Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW: Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. American Journal of Roentgenology 2004;183:1143-1147.

Pao W, Miller VA, Venkatraman E, Kris MG. Predicting sensitivity of non-small-cell lung cancer to gefitinib: is there a role for P-Akt? Journal of the National Cancer Institute 2004; 96:1117-1119.

Patel JD, Bach PB, Kris MG: Lung cancer in US women: A contemporary epidemic. Journal of the American Medical Association 2004;291:1763-1768.

Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MRM. LPAM(alpha(4)beta(7) integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 2004;103:1542-1547.

Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, Noy A, O'Connor O, Horwitz S, Moskowitz C, Filippa DA: Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. British Journal of Haematology 2004;125:701-708.

Portlock CS, Qin J, Schaindlin P, Roistacher N, Myers J, Filippa D, Louie D, Zelenetz AD, O'Brien JP, Moskowitz C, Norton L, Yahalom J, Straus DJ, Bertino JR: The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Annals of Oncology 2004;15:1495-1503.

Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML: Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecologic Oncology 2004;93:223-228.

Pucar D, Koutcher JA, Sha A, Dyke JP, Schwartz L, Thaler H, Kurhanewica J, Scardino PT, Kelly WK, Hricak H, Zakian KL. MRSI in predicting pathologic stage and PSA relapse in high-risk prosate cancer patients treated with aggressive neoadjuvant therapy prior to radical prostatectomy or radiation therapy. Clinical Prostate Cancer 2004;3:174-181.

Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC, Marshall JR. Report of high-dose selenium supplementation: repsonse and toxicities. Journal of Trace Elements in Medicine and Biology 2004;18:69-74.

Rengan R, Rosenzweig KE, Venkatraman E, Koutcher LA, Fox JL, Nayak R, Amols H, Yorke E, Jackson A, Ling CC, Leibel SA. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics 2004; 60:741-747.

Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW: The impact of complications on outcomes after resections for esophageal and gastroesophageal junction carcinoma. Journal of American College of Surgeons 2004;198:42-50.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Begin LR, Offit K, Foulkes WD: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Research and Treatment 2004;6:R8-R17.

Ryan CJ, Zelefsky MJ, Heller G, Regan K, Leibel SA, Scher HI, Kelly WK. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. Urology 2004;64:90-94.

Sabbatini P, Aghajanian C, Leitao M, Venkatraman E, Anderson S, Dupont J, Dizon D, O'Flaherty C, Bloss J, Chi D, Spriggs D. Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial. Clinical Cancer Research 2004;10:2962-2967.

Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Annals of Thoracic Surgery 2004;78:1734-1741

Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD: A note on competing risks in survival data analysis. British Journal of Cancer 2004;91:1229-1235.

Satagopan JM, Venkatraman ES, Begg CB: Two-stage designs for gene-disease association studies with sample size constraints. Biometrics 2004;60:589-597.

Satish Kumar M, Mrudula T, Mitra N, Bhanuprakash Reddy G: Enhanced degradation and decreased stability of eye lens alpha-crystallin upon methylglyoxal modification. Experimental Eye Research 2004;79:577-583.

Scher HI, Eisenberger M, D'Amico AV, Halabi S, Small EJ, Morris M, Kattan MW, Roach M, Kantoff P, Pienta KJ, Carducci MA, Agus D, Slovin SF, Heller G, Kelly WK Lange PH, Petrylak D, Berg W, Higano C, Wilding G, Moul JW, Partin AN, Logothetis C, Soule HR: Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. Journal of Clinical Oncology 2004;22:537-556. Erratum in: Journal of Clinical Oncology 2004;22:3205.

Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.

Schoder H. Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW: Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. Journal of Nuclear Medicine 2004;45:559-566.

Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD and Somerfield MR. American Society of Clinical Oncology Technology Assessment: Chemotherapy Sensitivity and Resistance Assays. Journal of Clinical Oncology 2004;22:3631-3638.

Schrag D: The price tag on progress--chemotherapy for colorectal cancer. New England Journal of Medicine 2004;351:317-319.

Sherman EJ, Rubin DM, Venkatraman E, Schwartz GK, Miller VA, Radzyner MH, Ruchlin HS, Spriggs D, Pfister DG. Using patients as their own controls for cost evaluation of phase I clinical trials. Journal of Clinical Oncology 2004;22:1308-1314.

Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, Suriawinata A, Paty PB, Minsky BD, Weiser MR, Temple LK, Wong WD, Klimstra DS: Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. American Journal of Surgical Pathology 2004;28:215-223.

Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja SS Osman I: Racial disparity of epidermal growth factor receptor expression in prostate cancer. Journal of Clinical Oncology 2004;22:4673-4677.

Sinha S, Mitra N, Kumar G, Bajaj K, Surolia A: Unfolding studies on Soybean agglutinin and Concanavalin A tetramers:A Comparative Account. Biophysical Journal 2004 [Epub ahead of print]

Stanziale SF, Petrowsky H, Adusumilli PS, Ben-Porat L, Gonen M, Fong Y: Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity. Clinical Cancer Research 2004;10:3225-3232.

Straus DJ, Portlock CS, Qin J, Myers J, Zelenetz AD, Moskowitz C, Nov A, Goy A, Yahalom J: Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood. 2004;104:3483-3489.

Takaro TK, Engel LS, Keifer M, Bigbee WL, Kavanagh TJ, Checkoway H: Glycophorin A is a potential biomarker for the mutagenic effects of pesticides. International Journal of Occupational Environmental Health 2004;10:256-261.

Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D: Use of surgery among elderly patients with stage IV colorectal cancer. Journal of Clinical Oncology 2004;22:3475-3484.

Venkatraman ES, Mitra N, Begg CB. A method for evaluating the impact of individual haplotypes on disease incidence in molecular epidemiology studies. Statistical Applications in Genetics and Molecular Biology 2004;3:1-20. http://www.bepress.com/sagmb/vol3/iss1/art27

Vickers AJ. Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covariance. Clinical Journal of Pain 2004;20(5):319-23

Vickers AJ, Cassileth BR, Strauss D. Acupuncture for post-chemotherapy fatigue: a Phase II study. Journal of Clinical Oncology 2004;22(9):1731-5

Vickers AJ. Statistical considerations for use of composite health-related quality-of-life scores in randomized trials. Quality of Life Research 2004;13 :717 -723

Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith C, Ellis N, Fisher P, Van Haselen R. Acupuncture for chronic headache in primary care: a large, pragmatic, randomised trial. British Medical Journal 2004;328:744-747.

Vickers A. Alternative cancer cures: "unproven" or "disproven"? CA Cancer J Clin. 2004;54(2):110-8.

Wagner JE, Tolar J, Levran O, Scholl T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish SD, Kutler DI, MacMillan ML, Hanenberg H, Auerbach AD: Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103:3226-3229.

Wang JC, Boland P, Mitra N, Yamada Y, Lis E, Stubblefield M, Bilsky MH. "Single-stage posterolateral transpedicular approach (PTA) for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: Results in 140 patients". Journal of Neurosurgery Spine 2004;1:287-98.

Weitz J, D'Angelica M, Jarnagin W, Gonen M, Fong Y, Blumgart L, Dematteo R: Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery 2004;135:273-281.

Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost-effectiveness analysis of a randomised trial of acupuncture for migraine and chronic tension headache in primary care. British Medical Journal 2004;328:747-9.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B: Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 2004;22:3965-3972.

Yoon SS, Segal NH, Olshen AB, Brennan MF, Singer S: Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Annals of Oncology 2004;15:1261-1266.

Zauber AG: Quality control for flexible sigmoidoscopy: which polyps count? Gastroenterology 2004;126:1474-1477.

Zauber P, Sabbath-Solitare M, Marotta S, Zauber A, Bishop T. Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual. Journal of Clinical Pthology 2004;57:1084-1088.